Paradoxically, PIK3CA mutations were reported to predict both a favorable or unfavorable prognosis, varying based on molecular subtype and tumor stage (Deng et al. 2015; Elfgen et al. 2019; Liu et al. 2014; Mosele, et al. 2020; Pang et al. 2014). Here, PIK3CA is linked to neoplasm.